Amicus Therapeutics, Inc.FOLDNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P23
Within normal range
vs 2Y Ago
-0.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -54.78% |
| Q3 2025 | 221.95% |
| Q2 2025 | -483.37% |
| Q1 2025 | 279.50% |
| Q4 2024 | 81.98% |
| Q3 2024 | -208.03% |
| Q2 2024 | 168.54% |
| Q1 2024 | -1924.32% |
| Q4 2023 | 104.33% |
| Q3 2023 | -117.68% |
| Q2 2023 | 8.38% |
| Q1 2023 | 76.02% |
| Q4 2022 | -626.34% |
| Q3 2022 | 29.15% |
| Q2 2022 | 72.60% |
| Q1 2022 | 18.11% |
| Q4 2021 | -193.92% |
| Q3 2021 | 32.24% |
| Q2 2021 | 50.44% |
| Q1 2021 | -43.89% |
| Q4 2020 | -20.33% |
| Q3 2020 | -22.27% |
| Q2 2020 | 68.19% |
| Q1 2020 | -58.16% |
| Q4 2019 | -15.50% |
| Q3 2019 | 1.85% |
| Q2 2019 | 25.57% |
| Q1 2019 | -30.56% |
| Q4 2018 | 53.92% |
| Q3 2018 | -133.31% |
| Q2 2018 | -15.33% |
| Q1 2018 | 32.79% |
| Q4 2017 | -46.64% |
| Q3 2017 | -17.50% |
| Q2 2017 | 14.06% |
| Q1 2017 | -56.02% |
| Q4 2016 | 22.43% |
| Q3 2016 | -21.25% |
| Q2 2016 | 27.92% |
| Q1 2016 | -25.56% |